
Home » Baebies’ Genetic Screening Assay Receives CE Mark
Baebies’ Genetic Screening Assay Receives CE Mark

Newborn screening and pediatric test developer Baebies has received a CE mark for assays that screen for two genetic disorders.
The galactosemia and biotinidase deficiency assays, which run on the company’s Seeker screening platform, use dried blood-spot specimens to detect reduced enzyme activity in newborns.
The Durham, N.C.-based company is launching the assays in Europe and other countries that recognize the CE mark.
Upcoming Events
-
01Feb
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb